Other
GSK (GSK LN) is in talks to buy cancer biotech Nuvalent (NUVL) for more than USD 9bln, according to FT
Related stocks
2 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
